A new drug that can potentially overcome cancer therapy resistance
Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts cancer cells' ability to survive therapy. The findings, published in Science Advances, support exploring the possibility of using CS18 ...
12 hours ago
0
42









